v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04770740 |
Full text link
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : June 14, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : June 14, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-02-25 |
Recruitment status
Last imported at : June 14, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : June 14, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - covid-19 patients who are admitted to the cwz with covid-19, with a laboratory confirmed sars-cov-2 infection within the previous 96 hours - respiratory failure requiring supplemental oxygen, defined as requiring supplemental oxygen to sustain an arterial po2 ≥70mmhg (measured by arterial blood gas) or an oxygen saturation of ≥94% (measured using a pulse oximeter) - at least 18 years old - able to safely swallow the study medication or possibility of safely administering this through a nasogastric tube - use of prophylactic heparin or lwmh according to hospital protocols, or use of therapeutic dosages if there is a medical indication for this - informed consent signed by patient |
Exclusion criteria
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
- use of oral anticoagulation drugs; patients may be included when they have been switched to lmwh - patients on vitamin k antagonists with a supra-therapeutic anticoagulation at admission who require vitamin k supplementation to correct this, or were administered vitamin k for this reason within the preceding 5 days - patients already using vitamin k supplements at admission - participation in another intervention study - direct admission to an intensive care unit (icu) for invasive ventilation at presentation - confirmed active pulmonary embolism or deep venous thrombosis prior to inclusion - known allergy to any of the components of the study medication or placebo - patients who are hemodialysis dependent at admission - pregnancy at the time of inclusion - diagnosed malignancy at the time of inclusion |
Number of arms
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Canisius-Wilhelmina Hospital |
Inclusion age min
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : March 5, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Netherlands |
Type of patients
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Severe disease at enrollment |
Severity scale
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
6: Severe disease at enrollment |
Total sample size
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
40 |
primary outcome
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Plasma desmosine levels;Plasma dp-ucMGP levels |
Notes
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : June 14, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Feb. 27, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1373, "treatment_name": "Vitamin k2", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |